GSK Brings Cervarix To India At Higher Price Than Merck's Gardasil; Will Gynecologists and Pediatricians Help GSK Grab Market Share?
• By PharmAsia News
MUMBAI - Overcoming a drawn-out registration and approval process, GlaxoSmithKline has finally launched its much awaited vaccine Cerverix in India. Cerverix is used for the prevention of pre-malignant cervical lesions and cervical cancer related to human pappilomavirus (HPV) types 16 and 18
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
